Opportunities for addiction care, HIV prevention in Russia

SPOKANE, Wash. – Opioid resistance therapy using methadone is regarded as one of the most effective treatments for opioid use disorders as well as for helping to reduce HIV risks. Such therapy, however, is not available in Russia.

Washington State University College of Nursing researcher Sean Murphy, with colleagues from Boston Medical Center and Brandeis University, conducted a study to estimate costs and reduction in disease burden if this treatment were implemented into the Russian health care system.

They found that providing methadone therapy to as few as 3.1 percent of people with opioid addiction would result in a substantial reduction in disease burden over 10 years at a cost of just over $17 million.

Read more about the study and findings at https://www.eurekalert.org/pub_releases/2017-01/bumc-ofa012017.php.

 

Next Story

Recent News

Aging societies more vulnerable to collapse

Societies and political structures, like the humans they serve, appear to become more fragile as they age, according to an analysis of hundreds of pre-modern societies.

Insider will return Monday, Nov. 27

WSU Insider is taking a break to join with the rest of the university community in celebrating the Thanksgiving holiday. We’ll be back the morning of Nov. 27 with fresh posts and all the latest WSU information.

Charting a clear path forward for WSU Athletics

Statement from WSU President Kirk Schulz and Director of Athletics Pat Chun about today’s ruling affirming that the future of the Pac‑12 should be determined by the members who remain in the conference rather than those who are leaving.

Marshall Scholar finalist Katy Ayers explores fungi

WSU senior Katy Ayers, a bioengineering major minoring in biochemistry and mathematics, is the latest finalist for a Marshall Scholarship to study in the United Kingdom.